Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Merrimack Pharmaceuticals Inc.
DescriptionCompanion diagnostic test to identify patients with tumors with dependency on ErbB3 signaling
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPhase I/II
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today